The effect of intradialytic exercise on calcium, phosphorus and parathyroid hormone: a randomized controlled trial
- PMID: 37730530
- PMCID: PMC10512624
- DOI: 10.1186/s12882-023-03327-7
The effect of intradialytic exercise on calcium, phosphorus and parathyroid hormone: a randomized controlled trial
Abstract
Background: Patients with kidney failure experience derangements of circulating markers of mineral metabolism and dysregulation of skeletal and cardiovascular physiology which results in high mortality rate in these patients. This study aimed to evaluate the effect of intradialytic exercise on regulation of these abnormalities in patients receiving chronic hemodialysis (HD).
Methods: In this randomized controlled trial conducted in an HD center in Iran, adult patients receiving chronic HD were randomized to intradialytic exercise (60 min) in the second hour of thrice weekly dialysis for 6 months (intervention) or no intradialytic exercise (control). The primary outcomes were serum calcium, serum phosphorous and parathyroid hormone levels. Secondary outcomes were serum alkaline phosphatase and calcium-phosphorous product.
Results: The study included 44 participants randomized to intervention (n = 22) or control (n = 22). During the 6-month intervention period, significant between-group changes were observed in all primary and secondary outcomes between the intervention and control groups. Statistical analyses reveal a significant increase in serum calcium (P < 0.05) as well as a significant decrease in serum phosphorous, parathyroid hormone, alkaline phosphatase and calcium-phosphorous product (P < 0.05).
Conclusion: Intradialytic exercise performed for at least 60 min during thrice weekly dialysis sessions improves bone mineral metabolism in adult patients receiving HD. Further studies should focus on observing and comparing the effect of different types of exercise on bone mineral disorders and all-cause mortality in HD patients.
Trial registration: ClinicalTrials.gov Identifier: NCT04916743, Registered on 08/06/2021. Registered trial name: The Effect of Intradialytic Exercise on Calcium, Phosphorous and Parathyroid Hormone: A Randomized Controlled Trial.
Keywords: Bone mineral disorders; Cardiovascular disease; Exercise during dialysis; Hematological parameters; Mortality.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
The effect of intradialytic exercise on dialysis patient survival: a randomized controlled trial.BMC Nephrol. 2023 Apr 17;24(1):100. doi: 10.1186/s12882-023-03158-6. BMC Nephrol. 2023. PMID: 37069527 Free PMC article. Clinical Trial.
-
Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1118-1127. doi: 10.2215/CJN.11931116. Epub 2017 May 9. Clin J Am Soc Nephrol. 2017. PMID: 28487345 Free PMC article.
-
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x. Hemodial Int. 2006. PMID: 17022745
-
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.Am J Kidney Dis. 2016 Nov;68(5S1):S24-S32. doi: 10.1053/j.ajkd.2016.05.024. Am J Kidney Dis. 2016. PMID: 27772640 Review.
-
Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review.JBI Database System Rev Implement Rep. 2019 Jan;17(1):49-73. doi: 10.11124/JBISRIR-2017-003740. JBI Database System Rev Implement Rep. 2019. PMID: 30204711
Cited by
-
Factors Influencing Recruitment, Retention, and Adherence Rates in Exercise Interventions in ESKD: A Scoping Review.Kidney Med. 2024 Nov 14;7(1):100933. doi: 10.1016/j.xkme.2024.100933. eCollection 2025 Jan. Kidney Med. 2024. PMID: 39810814 Free PMC article.
-
The comparison of serum bone-turnover markers in different stage of chronic kidney disease and the associated impact of intradialytic cycling in patients with end-stage renal disease.Aging (Albany NY). 2025 Jan 14;17(1):217-231. doi: 10.18632/aging.206177. Epub 2025 Jan 14. Aging (Albany NY). 2025. PMID: 39812596 Free PMC article.
-
The Clinical Efficacy Evaluation of the KHA-200 Hemoperfusion Device in the Treatment of End-Stage Renal Disease Patients Undergoing Blood Purification Therapy.Kidney Dis (Basel). 2025 Mar 29;11(1):270-282. doi: 10.1159/000545262. eCollection 2025 Jan-Dec. Kidney Dis (Basel). 2025. PMID: 40353218 Free PMC article.
References
-
- Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831–1843. - PubMed
-
- United States Renal Data System. Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018. Available at https://www.usrds.org/2018/view/Default.aspx.
-
- SONG Initiative. The SONG Handbook. Version 1.0 June 2017, Sydney,Australia Available at songinitiative.org/reports-and-publications/.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical